Therefore, the generation and maintenance of neutralizing antibodies against SARS-CoV-2, typically target the S protein and RBD fraction, which plays an important role in the resistance to infection by the host, blocking the interaction between the virus and the recipient host [43–45]. This evidence concerns the gene PROS1 and infection.